Nitric oxide therapy for dermatologic disease

References

• 1 Han G, Zippin JH, Friedman A. From bench to bedside: the therapeutic potential of nitric oxide in dermatology. J. Drugs Dermatol. 8(6), 586–594 (2009).
  MedlineGoogle Scholar
• 2 Kutner AJ, Friedman AJ. Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5(5), 502–514 (2013).
  Medline CASGoogle Scholar
• 3 Kuhn A, Fehsel K, Lehmann P, Krutmann J, Ruzicka T, Kolb-Bachofen V. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J. Invest. Dermatol. 111(1), 149–153 (1998).
  Medline CASGoogle Scholar
• 4 Ormerod AD, Dwyer CM, Reid A, Copeland P, Thompson WD. Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis. Acta Derm. Venereol. 77(6), 436–440 (1997).
  Medline CASGoogle Scholar
• 5 Ormerod AD, Weller R, Copeland P et al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch. Dermatol. Res. 290(1–2), 3–8 (1998).
  Medline CASGoogle Scholar
• 6 Rowe A, Farrell AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br. J. Dermatol. 136(1), 18–23 (1997).
  Medline CASGoogle Scholar
• 7 Hsu YC, Hsiao M, Wang LF, Chien YW, Lee WR. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation. Nitric Oxide 14(4), 327–334 (2006).
  Medline CASGoogle Scholar
• 8 Dooley A, Low SY, Holmes A et al. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis. Rheumatology (Oxford) 47(3), 272–280 (2008).
  Medline CASGoogle Scholar
• 9 Marquina M, Espana A, Fernandez-Galar M, Lopez-Zabalza MJ. The role of nitric oxide synthases in Pemphigus vulgaris in a mouse model. Br. J. Dermatol. 159(1), 68–76 (2008).
  Medline CASGoogle Scholar
• 10 Di Giunta G, Da Silva AM, Sotto MN. Inducible nitric oxide synthase in pityriasis lichenoides lesions. J. Cutan. Pathol. 36(3), 325–330 (2009).
  MedlineGoogle Scholar
• 11 Tsukazaki N, Watanabe M, Shimizu K, Hamasaki Y, Katayama I. Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjogren's syndrome associated with photosensitivity. Br. J. Dermatol. 147(6), 1102–1108 (2002).
  Medline CASGoogle Scholar
• 12 Lerner LH, Qureshi AA, Reddy BV, Lerner EA. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J. Invest. Dermatol. 114(1), 196–199 (2000).
  Medline CASGoogle Scholar
• 13 Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide 10(4), 179–193 (2004).
  Medline CASGoogle Scholar
• 14 Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23(2), 75–93 (2010).
  Medline CASGoogle Scholar
• 15 Wimalawansa SJ. Nitric oxide: new evidence for novel therapeutic indications. Expert Opin. Pharmacother. 9(11), 1935–1954 (2008).
  Medline CASGoogle Scholar
• 16 Ormerod AD, Copeland P, Shah SA. Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Br. J. Dermatol. 142(5), 985–990 (2000).
  Medline CASGoogle Scholar
• 17 Flavahan NA, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am. J. Hypertens. 8(5 Pt 2), S28–S41 (1995).
  Google Scholar
• 18 Hummers LK, Dugowson CE, Dechow FJ et al. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Ann. Rheum. Dis. 72(12), 1962–1967 (2012).
  MedlineGoogle Scholar
• 19 Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence 3(3), 271–279 (2012).
  MedlineGoogle Scholar
• 20 Jones ML, Ganopolsky JG, Labbe A, Wahl C, Prakash S. Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Appl. Microbiol. Biotechnol. 88(2), 401–407 (2010).
  Medline CASGoogle Scholar
• 21 Maclean A, Wei XQ, Huang FP, Al-Alem UA, Chan WL, Liew FY. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol. 79(Pt 4), 825–830 (1998).
  Medline CASGoogle Scholar
• 22 Macmicking JD, Nathan C, Hom G et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81(4), 641–650 (1995).
  Medline CASGoogle Scholar
• 23 Privett BJ, Broadnax AD, Bauman SJ, Riccio DA, Schoenfisch MH. Examination of bacterial resistance to exogenous nitric oxide. Nitric Oxide 26(3), 169–173 (2012).
  Medline CASGoogle Scholar
• 24 Englander L, Friedman A. Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection. J. Clin. Aesthet. Dermatol. 3(6), 45–50 (2010).
  MedlineGoogle Scholar
• 25 Ray GT, Suaya JA, Baxter R. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 76(1), 24–30 (2013).
  MedlineGoogle Scholar
• 26 Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. Population: a retrospective population-based study. BMC Infect. Dis. 13(1), 252 (2013).
  MedlineGoogle Scholar
• 27 Boucher HW, Talbot GH, Bradley JS et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48(1), 1–12 (2009).
  MedlineGoogle Scholar
• 28 Major TA, Panmanee W, Mortensen JE, Gray LD, Hoglen N, Hassett DJ. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother. 54(11), 4671–4677 (2010).
  Medline CASGoogle Scholar
• 29 Weller R, Price RJ, Ormerod AD, Benjamin N, Leifert C. Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida and bacterial skin pathogens. J. Appl. Microbiol. 90(4), 648–652 (2001).
  Medline CASGoogle Scholar
• 30 Chen C, Shi YQ, Song J, Qi QS, Gu L, Wang PG. Delivery of nitric oxide released from beta-Gal-NONOate activation by beta-galactosidase and its activity against Escherichia coli. Biol. Pharm. Bull. 29(6), 1239–1241 (2006).
  Medline CASGoogle Scholar
• 31 Mcelhaney-Feser GE, Raulli RE, Cihlar RL. Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob. Agents Chemother. 42(9), 2342–2346 (1998).
  Medline CASGoogle Scholar
• 32 Carpenter AW, Slomberg DL, Rao KS, Schoenfisch MH. Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. ACS Nano 5(9), 7235–7244 (2011).
  Medline CASGoogle Scholar
• 33 Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 30(14), 2782–2789 (2009).
  Medline CASGoogle Scholar
• 34 Ghaffari A, Neil DH, Ardakani A, Road J, Ghahary A, Miller CC. A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures. Nitric Oxide 12(3), 129–140 (2005).
  Medline CASGoogle Scholar
• 35 Ghaffari A, Miller CC, McMullin B, Ghahary A. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 14(1), 21–29 (2006).
  Medline CASGoogle Scholar
• 36 Miller C, Mcmullin B, Ghaffari A et al. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide 20(1), 16–23 (2009).
  Medline CASGoogle Scholar
• 37 Ghaffari A, Jalili R, Ghaffari M, Miller C, Ghahary A. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen. 15(3), 368–377 (2007).
  MedlineGoogle Scholar
• 38 Jones ML, Ganopolsky JG, Labbe A, Prakash S. A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl. Microbiol. Biotechnol. 87(2), 509–516 (2010).
  Medline CASGoogle Scholar
• 39 Jones M, Ganopolsky JG, Labbe A et al. Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. Int. Wound J. 9(3), 330–343 (2012).
  MedlineGoogle Scholar
• 40 Cariello AJ, Bispo PJ, De Souza GF, Pignatari AC, De Oliveira MG, Hofling-Lima AL. Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis. Clin. Ophthalmol. 6, 1907–1914 (2012).
  Medline CASGoogle Scholar
• 41 De Souza GF, Yokoyama-Yasunaka JK, Seabra AB, Miguel DC, De Oliveira MG, Uliana SR. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis. Nitric Oxide 15(3), 209–216 (2006).
  MedlineGoogle Scholar
• 42 Lopez-Jaramillo P, Ruano C, Rivera J et al. Treatment of cutaneous leishmaniasis with nitric-oxide donor. Lancet 351(9110), 1176–1177 (1998).
  Medline CASGoogle Scholar
• 43 Fox S, Wilkinson TS, Wheatley PS et al. NO-loaded Zn(²⁺)-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy. Acta Biomater. 6(4), 1515–1521 (2010).
  Medline CASGoogle Scholar
• 44 Narin G, Albayrak CB, Ulku S. Antibacterial and bactericidal activity of nitric oxide-releasing natural zeolite. Appl. Clay Sci. 50(4), 560–568 (2010).
  CASGoogle Scholar
• 45 Friedman A, Blecher K, Sanchez D et al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2(3), 217–221 (2011).
  MedlineGoogle Scholar
• 46 Martinez LR, Han G, Chacko M et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J. Invest. Dermatol. 129(10), 2463–2469 (2009).
  Medline CASGoogle Scholar
• 47 Mihu MR, Sandkovsky U, Han G, Friedman JM, Nosanchuk JD, Martinez LR. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence 1(2), 62–67 (2010).
  MedlineGoogle Scholar
• 48 Macherla C, Sanchez DA, Ahmadi MS et al. Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections. Front. Microbiol. 3, 1–9 (2012).
  MedlineGoogle Scholar
• 49 Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS ONE 4(11), e7804 (2009).
  MedlineGoogle Scholar
• 50 Schairer D, Martinez LR, Blecher K et al. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses. Virulence 3(1), 62–67 (2012).
  MedlineGoogle Scholar
• 51 Friedman AJ, Blecher K, Schairer D et al. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide 25(4), 381–386 (2011).
  Medline CASGoogle Scholar
• 52 Chouake J, Schairer D, Kutner A et al. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. J. Drugs Dermatol. 11(12), 1471–1477 (2012).
  Medline CASGoogle Scholar
• 53 Weller R. Nitric oxide: a key mediator in cutaneous physiology. Clin. Exp. Dermatol. 28(5), 511–514 (2003).
  Medline CASGoogle Scholar
• 54 Weller R, Schwentker A, Billiar TR, Vodovotz Y. Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis. Am. J. Physiol. Cell Physiol. 284(5), C1140–C1148 (2003).
  Medline CASGoogle Scholar
• 55 Sasaki M, Horikoshi T, Uchiwa H, Miyachi Y. Up-regulation of tyrosinase gene by nitric oxide in human melanocytes. Pigment Cell Res. 13(4), 248–252 (2000).
  Medline CASGoogle Scholar
• 56 Feelisch M, Kolb-Bachofen V, Liu D et al. Is sunlight good for our heart? Eur. Heart J. 31(9), 1041–1045 (2010).
  MedlineGoogle Scholar
• 57 Chen L, Hu JY, Wang SQ. The role of antioxidants in photoprotection: a critical review. J. Am. Acad. Dermatol. 67(5), 1013–1024 (2012).
  Medline CASGoogle Scholar
• 58 Seabra AB. Nitric oxide-releasing nanomaterials and skin care. In: Nanocosmetics and Nanomedicines. Beck R, Guterres S, Pohlmann A (Eds). Springer, NY, USA, 253–268 (2011).
  Google Scholar
• 59 Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case–control study within the Nurses’ Health Study. Int. J. Epidemiol. 35(6), 1514–1521 (2006).
  MedlineGoogle Scholar
• 60 Wink DA, Miranda KM, Espey MG et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox. Signal. 3(2), 203–213 (2001).
  Medline CASGoogle Scholar
• 61 Jariashvili K, Madhan B, Brodsky B, Kuchava A, Namicheishvili L, Metreveli N. UV damage of collagen: insights from model collagen peptides. Biopolymers 97(3), 189–198 (2012).
  Medline CASGoogle Scholar
• 62 Guy GP, Berkowitz Z, Watson M, Holman DM, Richardson LC. Indoor tanning among young non-hispanic white females. JAMA Intern. Med. 173(20), 1920–1922 (2013).
  MedlineGoogle Scholar